Software specialist Carebeans Limited has­­­ established an office in Monmouth, Wales, having secured a significant six-figure equity Investment for their leading social care management software from the Development Bank of Wales and Liverpool based MSIF.  The co-investment includes the trade and assets acquisition of the Software business of Standex Systems Limited and onboarding of five new staff who move to Carebeans from Standex UK.

Sanctus, one of the first organisations in the UK to offer proactive mental health support through 1-2-1 coaching for employees in the workplace, has closed a £4.25m investment round led by Scale Up Capital, and advised by the team at PWC Ventures. Launched in 2016 by James Routledge, Sanctus was born out of a desire to normalise the conversation around mental health at work and make proactive support more readily available to UK employees. 

ProVerum Limited, an Irish medical device company developing a minimally invasive solution to treat benign prostatic hyperplasia (BPH) in the doctor's office, has closed a €30 million Series A equity financing co-led by Gilde Healthcare Partners and Lightstone Ventures, including participation from existing investors.

Scalpel, a healthcare services company that automates surgical protocols using sensor-driven event detection technology, has received investment from Henley Business Angels members as part of their Pre-Series A funding round.

Future Fertility, a fertility technology company developing AI-enabled and non-invasive fertility solutions to optimize clinical decision making in fertility care and in vitro fertilization (IVF), has successfully raised a Series A financing round. The investment was led by M Ventures (the corporate venture capital arm of Merck KGaA, Darmstadt, Germany, a global fertility leader), with participation from Whitecap Venture Partners.

Foresight Group, a leading listed private equity and infrastructure investment manager, has announced a £3.5 million investment into Hospital Services Limited (HSL).

Cognomie, the Mental Fitness start-up, has raised £385,000 in its first crowdfunding campaign, set to drive global growth in 2022. The HRtech startup overfunded at 110% of its original £320k target, with a 5.90% equity stake in a pre-raise £6m valuation. It is expected that a Series A funding round will be announced this autumn.  Launched in 2019, Cognomie is on a mission to deliver Mental Fitness for everyone. Two years into the pandemic, the tech-enabled coaching platform has become a key resource for future-focused organisations seeking to proactively shape long-term employee wellbeing strategies and performance.

MedKitDoc, a German telemedicine platform, has raised 7 million euros in seed financing. In addition to Vorwerk Ventures, Acton Capital, and existing investor Picus Capital, FlixBus founders Daniel Krauss and Jochen Engert are also investing in the fast-growing digital health start-up based in Berlin and Hannoversch Münden.

Karmacist, the world’s first nutrigenomics-based wellness supplement, has closed a £700k pre-seed investment led by Founders Factory and travel entrepreneur Craig Burkinshaw, as it brings to market the world’s first wellness supplement that draws on the relationship between genetics and nutrients to support the growing numbers of consumers investing in their wellbeing. 

Glucose Republic (GR) has raised a £500,000 investment round from leading equity investors Deepbridge Capital and the Development Bank of Wales, to build the world’s first system focused on what  impact food has upon us.

Leading digital training solutions provider, WELL Training (WELL), has secured £625,000 funding from Midlands Engine Investment Fund (MEIF) West Midlands Equity Fund, managed by Midven, part of the Future Planet Capital Group, to drive its growth strategy in two main areas - increasing apprenticeship training capacity and expanding the use of its online digital training platform. 

NPIF - Maven Equity Finance, managed by Maven Capital Partners and part of the Northern Powerhouse Investment Fund (NPIF) has invested £500,000 in Advanced Bacterial Sciences Ltd, which creates, manufactures and sells biological solutions for a range of real-world pollution and maintenance problems. The funding will enable ABS to commercialise its portfolio of products, sell directly to end users, as well as invest in continuous product development, patenting future technologies and scientific advances.